SCHEMBL6006314

SCHEMBL6006314

CC(C=NNc1ccc(C#N)cc1)Oc1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
PTGS2 P35354 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
SIRT2 Q8IXJ6 1/20 0.37
HTT P42858 1/20 0.37
AR P10275 1/20 0.37
KMT2A Q03164 1/20 0.36
CCR6 P51684 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNA1B Q00975 1/20 0.36
FAAH O00519 1/20 0.35
MGLL Q99685 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
KDM1A O60341 1/20 0.35
IDO1 P14902 3/20 0.34
CYP19A1 P11511 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3369760 0.71 SMN1; SMN2 (0.47) CYP11B1CYP11B2PTGS2SMN1; SMN2HTT
SCHEMBL3369758 0.71 SMN1; SMN2 (0.47) CYP11B1CYP11B2PTGS2SMN1; SMN2HTT
SCHEMBL10951291 0.70 PTGS2 (0.57) CYP11B1CYP11B2PTGS2SMN1; SMN2HTT
SCHEMBL5458774 0.70 PTGS2 (0.57) CYP11B1CYP11B2PTGS2SIRT2CA12
SCHEMBL803901 0.70 PTGS2 (0.68) CYP11B1CYP11B2PTGS2CA12CA1
SCHEMBL23928537 0.68 MAPT (0.67) PTGS2SMN1; SMN2HTTKMT2AFAAH
SCHEMBL4190362 0.65 PTGS2 (0.72) CYP11B1CYP11B2PTGS2CA12CA1
SCHEMBL9529534 0.64 HTT (0.48) SMN1; SMN2HTTKMT2ACACNA1BCA12
SCHEMBL13892893 0.64 MMP2 (0.52) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL9034923 0.64 PTGS2 (0.55) PTGS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656347-A1 SUBSTITUTED INDOLE DERIVATIVES FOR PHARMACEUTICAL COMPOSITION FOR TREATING RESPIRATORY DISEASES Astrazeneca AB (SE) 2006-05-17 EP disclosed
WO-2005019171-A1 SUBSTITUTED INDOLE DERIVATIVES FOR PHARMACEUTICAL COMPOSITION FOR TREATING RESPIRATORY DISEASES ASTRAZENECA AB (SE) 2005-03-03 WO disclosed